When it comes to the treatment of glaucoma, there is growing evidence to suggest that the ability to re-establish the natural flow of aqueous humour plays a critical role not only in reducing IOP, but also in preserving the health of the corneal endothelium, says US ophthalmologist DR DAVID LUBECK.
Teenage siblings from Sydney with an inherited retinal disease have become the first in Australia to receive the Luxturna ocular gene therapy. Those involved with delivering the novel treatment say it has rescued their vision, with hopes it will prevent them from going blind. Read more
Melbourne researchers are developing a new gene therapy they hope will “switch on sight” by regenerating light-sensing photoreceptor cells in the retina. Read more
New eye drop formulations are making dry eye treatment more affordable and accessible, especially for more severe sufferers. But Australia has often played catch up, as RHIANNON BOWMAN reports.
Australian optometrists are not permitted to prescribe oral medication, in contrast to comparative countries where their counterparts have been prescribing them for years. Insight investigates why this is the case in Australia.
Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been involved in, investigating a new therapy she says is the only intervention shown to significantly slow the growth of lesions in dry AMD. Read more
MIGS has triggered a shift in the glaucoma paradigm, enabling surgical intervention that bridges the gap between medical management and invasive surgery. While much of the focus has been on stent-based procedures, DR NATHAN KERR says surgeons should be excited by an entirely different approach by Australia’s Nova Eye Medical.
The first corneal allogenic intrastromal ring segment (CAIRS) surgery in Australia has been performed at the Queensland Eye Institute (QEI), paving the way to better sight for keratoconus patients.
A new paper comparing axial elongation differences among untreated myopes, myopes fitted with a control contact lens and emmetropes has helped further the understanding of myopia control efficacy in the context of normal childhood eye growth. Read more
Glaukos has secured Australian regulatory approval for the Preserflo MicroShunt, offering late-stage glaucoma patients a more elegant surgical alternative to conventional filtration procedures. Read more